Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
10.41
+0.55 (5.63%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Greenwich LifeSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
3.061.631.561.040.81
Upgrade
Research & Development
12.957.76.483.561.06
Upgrade
Operating Expenses
16.019.338.044.61.86
Upgrade
Operating Income
-16.01-9.33-8.04-4.6-1.86
Upgrade
Interest & Investment Income
0.220.440.220.030
Upgrade
Pretax Income
-15.79-8.89-7.83-4.57-1.86
Upgrade
Net Income
-15.79-8.89-7.83-4.57-1.86
Upgrade
Net Income to Common
-15.79-8.89-7.83-4.57-1.86
Upgrade
Shares Outstanding (Basic)
131313139
Upgrade
Shares Outstanding (Diluted)
131313139
Upgrade
Shares Change (YoY)
1.29%-0.51%-0.23%36.27%320.69%
Upgrade
EPS (Basic)
-1.21-0.69-0.61-0.35-0.20
Upgrade
EPS (Diluted)
-1.21-0.69-0.61-0.35-0.20
Upgrade
EBITDA
-16.01-9.32-8.04-4.59-1.86
Upgrade
D&A For EBITDA
00000
Upgrade
EBIT
-16.01-9.33-8.04-4.6-1.86
Upgrade
Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q